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Abstract
Dengue is a widespread mosquito-borne infection in human beings, which in recent years has become a major
international public health concern. Symptomatic dengue virus infections can present with a wide range of clinical
manifestations, from a mild febrile illness to a life-threatening shock syndrome. Both viral and host factors are
thought to contribute to the manifestations of disease in each infected. It is important to understand its burden
on health care, morbidity and mortality. Early diagnosis and suspicion of DF in primary care might reduce the
complications if handled properly. We must understand the depth of the problem in terms of its transmission,
clinical presentation, diagnosis, management and prevention.
Background
The World health Organization (WHO) declares dengue
and dengue hemorrhagic fever to be endemic in South
Asia. WHO currently estimates there may be 50 million
dengue infections worldwide every year. In 2007 alone,
there were more than 890 000 reported cases of dengue
in the Americas, of which 26 000 cases were Dengue
Hemorrhagic Fever (DHF) [1]. The disease is now ende-
mic in more than 100 countries in Africa, Americas, the
Eastern Mediterranean, South-east Asia and the Wes-
tern Pacific. South-east Asia and the Western Pacific are
the most seriously affected.
Pakistan is at high risk of being hit by large epidemics
because of many over crowded cities, unsafe drinking
water, inadequate sanitation, large number of refugees
and low vaccination coverage. These conditions promote
the spread of infectious diseases and consequently every
year a large number of epidemics/outbreaks occur in
different parts of the country, which result in increased
morbidity and mortality.
Epidemiology
Global Burden
Dengue virus infection is increasingly recognized as one
of the world’s emerging infectious diseases. About
50-100 million cases of dengue fever and 500,000 cases
of Dengue Hemorrhagic Fever (DHF), resulting in
around 24,000 deaths, are reported annually [1].
A pandemic of dengue began in Southeast Asia after
World War II and has spread around the globe since
then. In the 1980 s, DHF began a second expansion into
Asia when Sri Lanka, India, and the Maldive Islands had
their first major DHF epidemics.
Local Prevalence
Pakistan first reported an epidemic of dengue fever in
1994.The epidemics in Sri Lanka and India were asso-
ciated with multiple dengue virus serotypes, but DEN-3
was predominant and was genetically distinct from DEN-3
viruses previously isolated from infected persons in those
countries. In Asian countries where DHF is endemic, the
epidemics have become progressively larger in the last
15 years. In 2005, dengue is the most important mosquito-
borne viral disease affecting humans [2].
D e n g u ev i r u si sn o we n d e m i ci n Pakistan, circulating
throughout the year with a peak incidence in the post
monsoon period. Recent flood in Pakistan made the
situation worse.
Dengue Surveillance Cell Sind province of Pakistan
reports 1,809 suspected Dengue out of which 881 con-
firmed till 11
th October 2010 with 5 deaths while 16 con-
firmed cases reported in Islamabad without any mortality.
Till now 563 confirmed cases were reported at our
institution since January 2010. Reported cases are
usually complicated or with hemorrhagic manifestation.
In primary health care the usual presentation is mild to
moderate fever treated as suspected dengue fever.
Researchers have identified that co-circulation of
D E N - 2a n dD E N - 3w a sr e s p o n s i b l ef o rt h e2 0 0 6o u t -
break in Karachi. Primary and secondary cases were
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association with DEN-2. Introduction of a new serotype
(DEN-3) and or a genotypic shift of endemic serotype
(DEN-2) are the probable factors for the recent out-
break of DHF in this region [3].
Transmission
Aedes Aegypti mosquito, which generally acquires the
virus while feeding on the blood of an infected person
and transmit the disease to another non infected person.
It is primarily a daytime feeder lives around human
habitation. This mosquito rests indoors, in closets and
other dark places. Outside, it rests where it is cool and
shaded. The female mosquito lays her eggs in water
containers in and around homes, schools and other
areas in towns or villages. These eggs become adults in
about 10 days. Dengue mosquitoes also breed in stored,
exposed, water collection systems. The favored breeding
places are: barrels, drums, jars, pots, buckets, flower
vases, plant saucers, tanks, discarded bottles/tins, tires,
or water coolers, and other places where rainwater col-
lects or stored.
Dengue infection is caused by any of 4 different sero-
types of the virus (DEN-1, DEN-2, DEN-3, and DEN-4).
After an incubation period of 2-8 days after an infective
mosquito bite, the disease usually begins with sudden
onset of fever and headache.
Clinical Features
WHO Case definition
Dengue fever is a severe, flu-like illness that affects
infants, young children and adults, but seldom causes
death. The clinical features of dengue fever vary accord-
ing to the age of the patient. Infants and young children
m a yh a v ean o n - s p e c i f i cf e b r i le illness with rash. Older
children and adults may have either a mild febrile syn-
drome or the classical incapacitating disease with abrupt
onset and high fever, severe headache, pain behind the
eyes, muscle and joint pains, and rash [4].
Common presentations in our clinical practice, high
grade fever typically accompanied by any of the follow-
ing: chilliness, retro-orbicular pain, photophobia, back-
ache, severe muscle ache (one synonym of dengue is
“break-bone fever”), and joint ache, nausea, vomiting,
abdominal pain. High fever may be sustained over 5-6
days. Other signs and symptoms include a generalized
maculopapular rash, lymph node enlargement, hepato
splenomegaly, a positive tourniquet test, petechiae, and
other hemorrhagic manifestations, such as epistaxis and
gastrointestinal bleeding. In some cases it started as
common cold and flu like symptoms. In general, conva-
lescence occurs spontaneously and abruptly, but it
might be prolonged, sometimes taking several weeks,
and may be accompanied by pronounced asthenia and
depression. In DHF characteristically, the overall vascu-
lar system is damaged, vascular instability, decreased
vascular integrity and platelet dysfunction resulting in
bleeding from different sites [5].
Clinical presentation may vary from undifferentiated
fever, classic dengue fever(DF), Dengue hemorrhagic
fever(DHF) to Dengue shock syndrome(DSS). The risk
of severe disease is much higher in sequential rather
than primary dengue infection [6].
Necessary Criteria for DHF:
■ Fever, or recent history of acute fever
■ Hemorrhagic manifestations
■ Low platelet count (100,000/mm
3 or less)
■ Objective evidence of “leaky capillaries:”
■ elevated hematocrit (20% or more over
baseline)
■ low albumin
■ pleural or other effusions
Grade 1 DHF: Fever and nonspecific constitutional
symptoms, Positive tourniqu e tt e s ti so n l yh e m o r r h a g i c
manifestation. Thrombocytopenia and rise in haemato-
crit level (more than 20%).
Grade 2 DHF: Grade 1 manifestations + spontaneous
bleeding, circulatory failure manifested by rapid and
weak pulse, narrowing of pulse pressure (20 mmHg or
less) or hypotension with the presence of cold clammy
skin and restlessness, Capillary relief time more than
two seconds. Thrombocytopenia and rise in haematocrit
level (more than 20%)
Grade 3 DHF/DSS: Signs of circulatory failure (rapid/
weak pulse, narrow pulse pressure, hypotension, cold/
clammy skin)
Grade 4 DHF/DSS: Profound shock (undetectable
pulse and BP), abdominal pain - intense and sustained,
persistent vomiting, abrupt change from fever to
hypothermia, with sweating and prostration, restlessness
or somnolence.
Laboratory Tests
Usually clinical suspicion for Dengue fever is sufficient
for supportive treatment. Complete blood picture may
show high hematocrit, leucopenia and thrombocytope-
nia. Other laboratory tests include serum albumin, chest
X Ray if required. A normal blood count does not rule
out DF however platelet <50,000 and leukocyte count
<3 might be a sign of bad prognosis.
Diagnosis of dengue fever or its complications is
e s t a b l i s h e db yc u l t u r eo ft h ev i r u si t s e l f ,b yd e t e c t i o no f
viral DNA with use of PCR, or by serological methods.
Although detection of specific IgM indicates fresh infec-
tion, a significant increase in IgG titer in paired serum
samples is also sufficient for diagnosing dengue fever.
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immunofluorescence tests, and hemagglutination assays.
Low white cell count, low platelet count, abnormal liver
function test, IgM ELISA test for serologic diagnosis,
IgM detecTable 5, 6 days after the onset of illness, IgG:
day 14 of illness in primary and day2 in secondary infec-
tions [7].
Pathophysiology
Studies has shown that median age of dengue patients
has decreased now and younger patients may be more
susceptible in the recent outbreak. Total and differential
leukocyte counts and platelet count may help identify
patients at risk of hemorrhage. Severity of disease
depends on virus strain, pre-existing anti-dengue anti-
body previous infection maternal antibodies in infants,
host genetics, age, secondary infections locations with
two or more serotypes circulating simultaneously at
high levels (hyperendemic transmission) and virus strain
(genotype) [8]. Epidemic potential is dependent on vire-
mia level, infectivity and virus serotype, DHF risk is
greatest for DEN-2, followed by DEN-3, DEN-4 and
DEN-1 [9]. Antibody-dependent enhancement is the
process in which certain strains of dengue virus, com-
plexed with non-neutralizing antibodies, can enter a
greater proportion of cells of the mononuclear lineage,
thus increasing virus production. Infected monocytes
release vasoactive mediators, resulting in increased vas-
cular permeability and hemorrhagic manifestations that
characterize DHF and DSS [10].
There are other febrile illness prevalent in Pakistan
like other viral infections, Malaria, Enteric fever and
Congo hemorrhagic fever which can cause leucopenia
and thrombocytopenia worth considering during the
investigation and relevant investigations are done
according to the clinical presentation [11,12].
Dengue IgM is a costly investigation not freely avail-
able although it confirms the diagnosis but never
changes the management.
Management
There is no specific treatment available the management
is entirely supportive like keeping body temperature
below 39°C, give the patient paracetamol (not more
than four times in 24 hours. Avoid Aspirin or Brufen/
Ponston. Advice to drink large amounts of fluids (water,
soups, milk and juices) along with the patient’sn o r m a l
diet. The patient should rest. Complete blood picture
should be done if fever is continue for three days. Oral
rehydration salt (ORS) should be started even there is
no significant clinical dehydration as patient can go in
rapid deterioration if dehydration commences. Primary
care physician can start intravenous fluid according to
the patients need it is life saving if administered on
proper time [13].
Clinical manifestation of impending hemorrhage are,
abdominal pain - intense and sustained, persistent
vomiting, abrupt change from fever to hypothermia,
with sweating and prostration, restlessness or somno-
lence, Thrombocytopenia <50,000, WBC <3.0, evidence
of “leaky capillaries:” high hematocrit (> 20% normal),
low albumin, pleural or other effusions needs urgent
referral for hospitalization.
Health education and Prevention
Primary care professionals have the potential and ability
to provide comprehensive care for most patients, given
adequate training, resources, and, when needed, specia-
list advice. General practitioners and community nurses
can play a major role in health education and hygiene
[14].
Effectiveness of Family physicians’ use of specific com-
munication skills in enhancing the care of the physical,
mental and emotional health of both their patients and
their families is essential.
Our health educational system needs to be updated
regularly, the information regarding Dengue Fever to be
made more generally available, the popular sources of
information like newspapers and television should be
used to disseminate information on a large scale [15].
Dengue mosquitoes bite during the daytime. Protec-
tion from the bite by wearing full-sleeve clothes and
long dresses to cover the limbs use of repellents, mos-
quito coils and electric vapour mats during the daytime.
Insecticide treated nets (ITNs) are available to protect
young children, pregnant women, old people, in addition
to others who may rest during the day. Curtains (cloth
or bamboo) can also be treated with insecticide and
hung at windows or doorways, to repel or kill mosqui-
toes. Drainage of water from desert/window air coolers
when not in use, in addition to tanks, barrels, drums,
and buckets. Remove all objects containing water such
as plant saucers from the house. All stored water con-
tainers should be kept covered at all times. Collect and
destroy discarded containers in which water collects,
such as bottles, plastic bags, tins, tyres, etc.
Vector control is implemented using environmental
management and chemical methods [16]. Proper solid
waste disposal and improved water storage practices,
including covering containers to prevent access by egg
laying female mosquitoes, are encouraged through com-
munity-based programs [17]. The application of appro-
priate insecticides to larval habitats, particularly those
used by the households, such as water storage vessels
can prevent mosquito breeding for several weeks there-
fore these insecticides must be used periodically [18].
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morbidity in Pakistan. The best health outcome depends
upon accurate diagnosis and appropriate treatment. A
patient centered communication provides a more com-
plete clinical picture which leads to improvement in
health outcomes such as symptom resolution, reduced
psychological distress, improvement of health and func-
tional status, relief from pain and anxiety control.
Conclusion
Family Physicians have a vital and active role to play in
providing care, support and identifying the sign of
impending hemorrhage which is serious consequences
of Dengue Fever needs referral to tertiary care for intra-
venous fluid replacement, platelet transfusion along with
supportive care. Family practice also has opportunity for
research-based evidence on Dengue fever more interven-
tional research is required in community to eradicate
this problem.
On-going public awareness campaign need to be
strengthened and vigorous campaign need to be initiated
at all levels. Family doctors in primary health care set-
ting have an opportunity not only give the best possible
supportive care to their patients but also educate them
regarding the spread of Dengue fever and vector control.
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